Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 13722 entries
Sorted by: Best Match Show Resources per page
Genetic Association of Hematopoietic Stem Cell Transplantation Outcome beyond Histocompatibility Genes.

Frontiers in immunology

Gam R, Shah P, Crossland RE, Norden J, Dickinson AM, Dressel R.
PMID: 28421078
Front Immunol. 2017 Apr 03;8:380. doi: 10.3389/fimmu.2017.00380. eCollection 2017.

The outcome of hematopoietic stem cell transplantation (HSCT) is controlled by genetic factors among which the leukocyte antigen human leukocyte antigen (HLA) matching is most important. In addition, minor histocompatibility antigens and non-HLA gene polymorphisms in genes controlling immune...

Cite
Gam R, Shah P, Crossland RE, et al. Genetic Association of Hematopoietic Stem Cell Transplantation Outcome beyond Histocompatibility Genes. Front Immunol. 2017;8:380doi: 10.3389/fimmu.2017.00380.
Gam, R., Shah, P., Crossland, R. E., Norden, J., Dickinson, A. M., & Dressel, R. (2017). Genetic Association of Hematopoietic Stem Cell Transplantation Outcome beyond Histocompatibility Genes. Frontiers in immunology, 8380. https://doi.org/10.3389/fimmu.2017.00380
Gam, Rihab, et al. "Genetic Association of Hematopoietic Stem Cell Transplantation Outcome beyond Histocompatibility Genes." Frontiers in immunology vol. 8 (2017): 380. doi: https://doi.org/10.3389/fimmu.2017.00380
Gam R, Shah P, Crossland RE, Norden J, Dickinson AM, Dressel R. Genetic Association of Hematopoietic Stem Cell Transplantation Outcome beyond Histocompatibility Genes. Front Immunol. 2017 Apr 03;8:380. doi: 10.3389/fimmu.2017.00380. eCollection 2017. PMID: 28421078; PMCID: PMC5377073.
Copy Download .nbib Format: NLM
The regulation of hydroxysteroid 17β-dehydrogenase type 1 and 2 gene expression in breast cancer cell lines by estradiol, dihydrotestosterone, microRNAs, and genes related to breast cancer.

Oncotarget

Hilborn E, Stål O, Alexeyenko A, Jansson A.
PMID: 28977936
Oncotarget. 2017 Jul 10;8(37):62183-62194. doi: 10.18632/oncotarget.19136. eCollection 2017 Sep 22.

AIM: To investigate the influence of estrogen, androgen, microRNAs, and genes implicated in breast cancer on the expression of HSD17B1 and HSD17B2.MATERIALS: Breast cancer cell lines ZR-75-1, MCF7, T47D, SK-BR-3, and the immortalized epithelial cell line MCF10A were used....

Cite
Hilborn E, Stål O, Alexeyenko A, et al. The regulation of hydroxysteroid 17β-dehydrogenase type 1 and 2 gene expression in breast cancer cell lines by estradiol, dihydrotestosterone, microRNAs, and genes related to breast cancer. Oncotarget. 2017;8(37):62183-62194doi: 10.18632/oncotarget.19136.
Hilborn, E., Stål, O., Alexeyenko, A., & Jansson, A. (2017). The regulation of hydroxysteroid 17β-dehydrogenase type 1 and 2 gene expression in breast cancer cell lines by estradiol, dihydrotestosterone, microRNAs, and genes related to breast cancer. Oncotarget, 8(37), 62183-62194. https://doi.org/10.18632/oncotarget.19136
Hilborn, Erik, et al. "The regulation of hydroxysteroid 17β-dehydrogenase type 1 and 2 gene expression in breast cancer cell lines by estradiol, dihydrotestosterone, microRNAs, and genes related to breast cancer." Oncotarget vol. 8,37 (2017): 62183-62194. doi: https://doi.org/10.18632/oncotarget.19136
Hilborn E, Stål O, Alexeyenko A, Jansson A. The regulation of hydroxysteroid 17β-dehydrogenase type 1 and 2 gene expression in breast cancer cell lines by estradiol, dihydrotestosterone, microRNAs, and genes related to breast cancer. Oncotarget. 2017 Jul 10;8(37):62183-62194. doi: 10.18632/oncotarget.19136. eCollection 2017 Sep 22. PMID: 28977936; PMCID: PMC5617496.
Copy Download .nbib Format: NLM
Noncoding RNA in drug resistant sarcoma.

Oncotarget

Li X, Shen JK, Hornicek FJ, Xiao T, Duan Z.
PMID: 28978183
Oncotarget. 2017 Jul 06;8(40):69086-69104. doi: 10.18632/oncotarget.19029. eCollection 2017 Sep 15.

Sarcomas are a group of malignant tumors that arise from mesenchymal origin. Despite significant development of multidisciplinary treatments for sarcoma, survival rates have reached a plateau. Chemotherapy has been extensively used for sarcoma treatment; however, the development of drug...

Cite
Li X, Shen JK, Hornicek FJ, et al. Noncoding RNA in drug resistant sarcoma. Oncotarget. 2017;8(40):69086-69104doi: 10.18632/oncotarget.19029.
Li, X., Shen, J. K., Hornicek, F. J., Xiao, T., & Duan, Z. (2017). Noncoding RNA in drug resistant sarcoma. Oncotarget, 8(40), 69086-69104. https://doi.org/10.18632/oncotarget.19029
Li, Xiaoyang, et al. "Noncoding RNA in drug resistant sarcoma." Oncotarget vol. 8,40 (2017): 69086-69104. doi: https://doi.org/10.18632/oncotarget.19029
Li X, Shen JK, Hornicek FJ, Xiao T, Duan Z. Noncoding RNA in drug resistant sarcoma. Oncotarget. 2017 Jul 06;8(40):69086-69104. doi: 10.18632/oncotarget.19029. eCollection 2017 Sep 15. PMID: 28978183; PMCID: PMC5620323.
Copy Download .nbib Format: NLM
MicroRNAs as regulators of apoptosis mechanisms in cancer.

Clujul medical (1957)

Pileczki V, Cojocneanu-Petric R, Maralani M, Neagoe IB, Sandulescu R.
PMID: 27004025
Clujul Med. 2016;89(1):50-5. doi: 10.15386/cjmed-512. Epub 2016 Jan 15.

MicroRNAs or miRNAs are small non-coding RNAs that regulate gene expression. Their discovery has brought new knowledge in biological processes of cancer. Involvement of miRNAs in cancer development includes several major pathways from cell transformation to tumor cell development,...

Cite
Pileczki V, Cojocneanu-Petric R, Maralani M, et al. MicroRNAs as regulators of apoptosis mechanisms in cancer. Clujul Med. 2016;89(1):50-5doi: 10.15386/cjmed-512.
Pileczki, V., Cojocneanu-Petric, R., Maralani, M., Neagoe, I. B., & Sandulescu, R. (2016). MicroRNAs as regulators of apoptosis mechanisms in cancer. Clujul medical (1957), 89(1), 50-5. https://doi.org/10.15386/cjmed-512
Pileczki, Valentina, et al. "MicroRNAs as regulators of apoptosis mechanisms in cancer." Clujul medical (1957) vol. 89,1 (2016): 50-5. doi: https://doi.org/10.15386/cjmed-512
Pileczki V, Cojocneanu-Petric R, Maralani M, Neagoe IB, Sandulescu R. MicroRNAs as regulators of apoptosis mechanisms in cancer. Clujul Med. 2016;89(1):50-5. doi: 10.15386/cjmed-512. Epub 2016 Jan 15. PMID: 27004025; PMCID: PMC4777469.
Copy Download .nbib Format: NLM
MicroRNA-138 attenuates epithelial-to-mesenchymal transition by targeting SOX4 in clear cell renal cell carcinoma.

American journal of translational research

Liu F, Wu L, Wang A, Xu Y, Luo X, Liu X, Hua Y, Zhang D, Wu S, Lin T, He D, Wei G, Chen S.
PMID: 28861152
Am J Transl Res. 2017 Aug 15;9(8):3611-3622. eCollection 2017.

MicroRNAs (miRNAs) are small, non-coding RNAs which can serve as oncogenes or tumor suppressor genes in human cancers. Herein, the transcriptomic differences of miRNAs in ccRCC were globally assessed using publicly available microarray dataset (GSE71302) from Gene Expression Omnibus...

Cite
Liu F, Wu L, Wang A, et al. MicroRNA-138 attenuates epithelial-to-mesenchymal transition by targeting SOX4 in clear cell renal cell carcinoma. Am J Transl Res. 2017;9(8):3611-3622
Liu, F., Wu, L., Wang, A., Xu, Y., Luo, X., Liu, X., Hua, Y., Zhang, D., Wu, S., Lin, T., He, D., Wei, G., & Chen, S. (2017). MicroRNA-138 attenuates epithelial-to-mesenchymal transition by targeting SOX4 in clear cell renal cell carcinoma. American journal of translational research, 9(8), 3611-3622.
Liu, Feng, et al. "MicroRNA-138 attenuates epithelial-to-mesenchymal transition by targeting SOX4 in clear cell renal cell carcinoma." American journal of translational research vol. 9,8 (2017): 3611-3622.
Liu F, Wu L, Wang A, Xu Y, Luo X, Liu X, Hua Y, Zhang D, Wu S, Lin T, He D, Wei G, Chen S. MicroRNA-138 attenuates epithelial-to-mesenchymal transition by targeting SOX4 in clear cell renal cell carcinoma. Am J Transl Res. 2017 Aug 15;9(8):3611-3622. eCollection 2017. PMID: 28861152; PMCID: PMC5575175.
Copy Download .nbib Format: NLM
MiR-210-3p inhibits the tumor growth and metastasis of bladder cancer via targeting fibroblast growth factor receptor-like 1.

American journal of cancer research

Yang X, Shi L, Yi C, Yang Y, Chang L, Song D.
PMID: 28861329
Am J Cancer Res. 2017 Aug 01;7(8):1738-1753. eCollection 2017.

Current evidence indicates that microRNAs are widely down-regulated in various tumors including colorectal carcinoma, liver cancer and lung cancer, and function as tumor suppressors through inhibiting cancer cell growth, invasion and migration. Here, we demonstrated that miR-210-3p level was...

Cite
Yang X, Shi L, Yi C, et al. MiR-210-3p inhibits the tumor growth and metastasis of bladder cancer via targeting fibroblast growth factor receptor-like 1. Am J Cancer Res. 2017;7(8):1738-1753
Yang, X., Shi, L., Yi, C., Yang, Y., Chang, L., & Song, D. (2017). MiR-210-3p inhibits the tumor growth and metastasis of bladder cancer via targeting fibroblast growth factor receptor-like 1. American journal of cancer research, 7(8), 1738-1753.
Yang, Xiaoming, et al. "MiR-210-3p inhibits the tumor growth and metastasis of bladder cancer via targeting fibroblast growth factor receptor-like 1." American journal of cancer research vol. 7,8 (2017): 1738-1753.
Yang X, Shi L, Yi C, Yang Y, Chang L, Song D. MiR-210-3p inhibits the tumor growth and metastasis of bladder cancer via targeting fibroblast growth factor receptor-like 1. Am J Cancer Res. 2017 Aug 01;7(8):1738-1753. eCollection 2017. PMID: 28861329; PMCID: PMC5574945.
Copy Download .nbib Format: NLM
MicroRNAs and Chinese Medicinal Herbs: New Possibilities in Cancer Therapy.

Cancers

Hong M, Wang N, Tan HY, Tsao SW, Feng Y.
PMID: 26305257
Cancers (Basel). 2015 Aug 24;7(3):1643-57. doi: 10.3390/cancers7030855.

In recent decades Chinese medicine has been used worldwide as a complementary and alternative medicine to treat cancer. Plenty of studies have shown that microRNAs (miRNAs) play fundamental roles in many pathological processes, including cancer, while the anti-cancer mechanisms...

Cite
Hong M, Wang N, Tan HY, et al. MicroRNAs and Chinese Medicinal Herbs: New Possibilities in Cancer Therapy. Cancers (Basel). 2015;7(3):1643-57doi: 10.3390/cancers7030855.
Hong, M., Wang, N., Tan, H. Y., Tsao, S. W., & Feng, Y. (2015). MicroRNAs and Chinese Medicinal Herbs: New Possibilities in Cancer Therapy. Cancers, 7(3), 1643-57. https://doi.org/10.3390/cancers7030855
Hong, Ming, et al. "MicroRNAs and Chinese Medicinal Herbs: New Possibilities in Cancer Therapy." Cancers vol. 7,3 (2015): 1643-57. doi: https://doi.org/10.3390/cancers7030855
Hong M, Wang N, Tan HY, Tsao SW, Feng Y. MicroRNAs and Chinese Medicinal Herbs: New Possibilities in Cancer Therapy. Cancers (Basel). 2015 Aug 24;7(3):1643-57. doi: 10.3390/cancers7030855. PMID: 26305257; PMCID: PMC4586788.
Copy Download .nbib Format: NLM
From trash to treasure: The untapped potential of endothelial microparticles in neurovascular diseases.

Pathophysiology : the official journal of the International Society for Pathophysiology

Yun JW, Xiao A, Tsunoda I, Minagar A, Alexander JS.
PMID: 27531185
Pathophysiology. 2016 Dec;23(4):265-274. doi: 10.1016/j.pathophys.2016.08.004. Epub 2016 Aug 12.

Discovered in 1947, microparticles (MP) represent a group of sub-micron cell-derived particles isolated by high speed centrifugation. Once regarded as cellular 'trash', in the past decade MP have gained tremendous attention in both basic sciences and medical research both...

Cite
Yun JW, Xiao A, Tsunoda I, et al. From trash to treasure: The untapped potential of endothelial microparticles in neurovascular diseases. Pathophysiology. 2016;23(4):265-274doi: 10.1016/j.pathophys.2016.08.004.
Yun, J. W., Xiao, A., Tsunoda, I., Minagar, A., & Alexander, J. S. (2016). From trash to treasure: The untapped potential of endothelial microparticles in neurovascular diseases. Pathophysiology : the official journal of the International Society for Pathophysiology, 23(4), 265-274. https://doi.org/10.1016/j.pathophys.2016.08.004
Yun, J Winny, et al. "From trash to treasure: The untapped potential of endothelial microparticles in neurovascular diseases." Pathophysiology : the official journal of the International Society for Pathophysiology vol. 23,4 (2016): 265-274. doi: https://doi.org/10.1016/j.pathophys.2016.08.004
Yun JW, Xiao A, Tsunoda I, Minagar A, Alexander JS. From trash to treasure: The untapped potential of endothelial microparticles in neurovascular diseases. Pathophysiology. 2016 Dec;23(4):265-274. doi: 10.1016/j.pathophys.2016.08.004. Epub 2016 Aug 12. PMID: 27531185.
Copy Download .nbib Format: NLM
Cancer stem cells as a potential therapeutic target in thyroid carcinoma.

Oncology letters

Vicari L, Colarossi C, Giuffrida D, De Maria R, Memeo L.
PMID: 27698787
Oncol Lett. 2016 Oct;12(4):2254-2260. doi: 10.3892/ol.2016.4936. Epub 2016 Aug 02.

A number of studies have indicated that tumor growth and proliferation is dependent on a small subset of cells, defined as cancer stem cells (CSCs). CSCs have the capability to self-renew, and are involved with cancer propagation, relapse and...

Cite
Vicari L, Colarossi C, Giuffrida D, et al. Cancer stem cells as a potential therapeutic target in thyroid carcinoma. Oncol Lett. 2016;12(4):2254-2260doi: 10.3892/ol.2016.4936.
Vicari, L., Colarossi, C., Giuffrida, D., De Maria, R., & Memeo, L. (2016). Cancer stem cells as a potential therapeutic target in thyroid carcinoma. Oncology letters, 12(4), 2254-2260. https://doi.org/10.3892/ol.2016.4936
Vicari, Luisa, et al. "Cancer stem cells as a potential therapeutic target in thyroid carcinoma." Oncology letters vol. 12,4 (2016): 2254-2260. doi: https://doi.org/10.3892/ol.2016.4936
Vicari L, Colarossi C, Giuffrida D, De Maria R, Memeo L. Cancer stem cells as a potential therapeutic target in thyroid carcinoma. Oncol Lett. 2016 Oct;12(4):2254-2260. doi: 10.3892/ol.2016.4936. Epub 2016 Aug 02. PMID: 27698787; PMCID: PMC5038376.
Copy Download .nbib Format: NLM
Tumor exosomal microRNAs thwarting anti-tumor immune responses in nasopharyngeal carcinomas.

Annals of translational medicine

Kapetanakis NI, Baloche V, Busson P.
PMID: 28480200
Ann Transl Med. 2017 Apr;5(7):164. doi: 10.21037/atm.2017.03.57.

No abstract available.

Cite
Kapetanakis NI, Baloche V, Busson P. Tumor exosomal microRNAs thwarting anti-tumor immune responses in nasopharyngeal carcinomas. Ann Transl Med. 2017;5(7):164doi: 10.21037/atm.2017.03.57.
Kapetanakis, N. I., Baloche, V., & Busson, P. (2017). Tumor exosomal microRNAs thwarting anti-tumor immune responses in nasopharyngeal carcinomas. Annals of translational medicine, 5(7), 164. https://doi.org/10.21037/atm.2017.03.57
Kapetanakis, Nikiforos-Ioannis, et al. "Tumor exosomal microRNAs thwarting anti-tumor immune responses in nasopharyngeal carcinomas." Annals of translational medicine vol. 5,7 (2017): 164. doi: https://doi.org/10.21037/atm.2017.03.57
Kapetanakis NI, Baloche V, Busson P. Tumor exosomal microRNAs thwarting anti-tumor immune responses in nasopharyngeal carcinomas. Ann Transl Med. 2017 Apr;5(7):164. doi: 10.21037/atm.2017.03.57. PMID: 28480200; PMCID: PMC5401680.
Copy Download .nbib Format: NLM
STRIP2 Is Indispensable for the Onset of Embryonic Stem Cell Differentiation.

Molecular therapy. Methods & clinical development

Sabour D, Srinivasan SP, Rohani S, Wagh V, Gaspar JA, Panek D, Ardestani MA, Doss MX, Riet N, Abken H, Hescheler J, Papadopoulos S, Sachinidis A.
PMID: 28480311
Mol Ther Methods Clin Dev. 2017 Apr 14;5:116-129. doi: 10.1016/j.omtm.2017.04.001. eCollection 2017 Jun 16.

The role of striatin interacting protein 2 (Strip2) in differentiation of embryonic stem cells (ESCs) is still under debate. Strip2-silenced murine (KD) ESCs were differentiated for 4, 8, 12, and 16 days. We show that Strip2 is distributed in...

Cite
Sabour D, Srinivasan SP, Rohani S, et al. STRIP2 Is Indispensable for the Onset of Embryonic Stem Cell Differentiation. Mol Ther Methods Clin Dev. 2017;5:116-129doi: 10.1016/j.omtm.2017.04.001.
Sabour, D., Srinivasan, S. P., Rohani, S., Wagh, V., Gaspar, J. A., Panek, D., Ardestani, M. A., Doss, M. X., Riet, N., Abken, H., Hescheler, J., Papadopoulos, S., & Sachinidis, A. (2017). STRIP2 Is Indispensable for the Onset of Embryonic Stem Cell Differentiation. Molecular therapy. Methods & clinical development, 5116-129. https://doi.org/10.1016/j.omtm.2017.04.001
Sabour, Davood, et al. "STRIP2 Is Indispensable for the Onset of Embryonic Stem Cell Differentiation." Molecular therapy. Methods & clinical development vol. 5 (2017): 116-129. doi: https://doi.org/10.1016/j.omtm.2017.04.001
Sabour D, Srinivasan SP, Rohani S, Wagh V, Gaspar JA, Panek D, Ardestani MA, Doss MX, Riet N, Abken H, Hescheler J, Papadopoulos S, Sachinidis A. STRIP2 Is Indispensable for the Onset of Embryonic Stem Cell Differentiation. Mol Ther Methods Clin Dev. 2017 Apr 14;5:116-129. doi: 10.1016/j.omtm.2017.04.001. eCollection 2017 Jun 16. PMID: 28480311; PMCID: PMC5415327.
Copy Download .nbib Format: NLM
The negative regulation of miR-149-5p in melanoma cell survival and apoptosis by targeting LRIG2.

American journal of translational research

Chen W, Zhang J, Xu H, Dai J, Zhang X.
PMID: 28979706
Am J Transl Res. 2017 Sep 15;9(9):4331-4340. eCollection 2017.

MicroRNAs (miRNAs) are key regulators of diverse biological processes in tumor progression including melanoma. LRIG2 is reported as an oncogene in cancer, however, little is known regarding the molecular and functions of LRIG2 in melanoma. In this study, we...

Cite
Chen W, Zhang J, Xu H, et al. The negative regulation of miR-149-5p in melanoma cell survival and apoptosis by targeting LRIG2. Am J Transl Res. 2017;9(9):4331-4340
Chen, W., Zhang, J., Xu, H., Dai, J., & Zhang, X. (2017). The negative regulation of miR-149-5p in melanoma cell survival and apoptosis by targeting LRIG2. American journal of translational research, 9(9), 4331-4340.
Chen, Wenqi, et al. "The negative regulation of miR-149-5p in melanoma cell survival and apoptosis by targeting LRIG2." American journal of translational research vol. 9,9 (2017): 4331-4340.
Chen W, Zhang J, Xu H, Dai J, Zhang X. The negative regulation of miR-149-5p in melanoma cell survival and apoptosis by targeting LRIG2. Am J Transl Res. 2017 Sep 15;9(9):4331-4340. eCollection 2017. PMID: 28979706; PMCID: PMC5622275.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 13722 entries